Skip to content
value.today

Synaptive Medical Inc.

Total raised
$32 M
6 rounds on record
Latest round
$5 M
Mar 2019
First round on record
Jun 2015
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Synaptive Medical Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2019$5 MNo. 6$2 to $10 million

Synaptive Medical Inc.: Raise no. 6, Mar 2019

Investors in this round

1 investor had bought by the notice of Apr 12, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ontario, Canada

People named in the notice

  • Cameron Piron · Executive Officer, Director
  • David Bruce Gallop · Executive Officer, Director
  • Peter Lee Wehrly · Executive Officer, Director
  • Sandra Glen Clarke · Executive Officer
  • Andrew Glen Prozes · Director
  • David Glen Caluori · Director
  • Douglas Glen Janzen · Director
  • Glenn Daniel Steele Jr. · Director
  • Wesley Hodges · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peter Wehrly, Director. Source: SEC Form D, newest notice filed Apr 12, 2019. Read the notice at the SEC.

debt, optionsSEC
Nov 2018$5 MNo. 5$2 to $10 million

Synaptive Medical Inc.: Raise no. 5, Nov 2018

Investors in this round

1 investor had bought by the notice of Dec 13, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ontario, Canada

People named in the notice

  • Cameron Piron · Executive Officer, Director
  • David Bruce Gallop · Executive Officer, Director
  • George Peter Dans · Executive Officer
  • Peter Lee Wehrly · Executive Officer, Director
  • Andrew Glen Prozes · Director
  • David Peter Caluori · Director
  • Douglas Glen Janzen · Director
  • Glenn Daniel Steele Jr. · Director
  • Wesley Hodges · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peter Wehrly, Director. Source: SEC Form D, newest notice filed Dec 13, 2018. Read the notice at the SEC.

debt, optionsSEC
Jun 2017$14 MNo. 4$10 to $50 million

Synaptive Medical Inc.: Raise no. 4, Jun 2017

Investors in this round

18 investors had bought by the notice of Jul 17, 2017: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ontario, Canada

People named in the notice

  • Cameron Piron · Executive Officer, Director
  • David Bruce Gallop · Executive Officer, Director
  • George Peter Dans · Executive Officer
  • Peter Lee Wehrly · Executive Officer, Director
  • Vincent Patrick Luciani · Executive Officer
  • William Patrick Ryan · Executive Officer
  • Andrew Glen Prozes · Director
  • David Patrick Caluori · Director
  • Douglas Glen Janzen · Director
  • Glenn Daniel Steele Jr. · Director
  • Michael DeMane · Director
  • Richard Lee Butland · Director
  • Wesley Hodges · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Cameron Piron, President. Source: SEC Form D, newest notice filed Jul 17, 2017. Read the notice at the SEC.

equity, optionsSEC
Sep 2016$3 MNo. 3$2 to $10 million

Synaptive Medical Inc.: Raise no. 3, Sep 2016

Investors in this round

18 investors had bought by the notice of Oct 7, 2016: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ontario, Canada

People named in the notice

  • Cameron Piron · Executive Officer, Director
  • David Gallop · Executive Officer, Director
  • Gal Sela · Executive Officer, Director
  • Wesley Hodges · Executive Officer, Director
  • Andrew Prozes · Director
  • Doug Janzen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Conversions have been made from Canadian dollars to US dollars using an estimated $CAD 1.3171/$USD 1.00 exchange rate, as of close of business on September 23, 2016.”

Signed by Cameron Piron, President. Source: SEC Form D and 1 amendment, newest notice filed Oct 7, 2016. Read the notice at the SEC.

equitySEC
Dec 2015$2 MNo. 2$2 to $10 million

Synaptive Medical Inc.: Raise no. 2, Dec 2015

Investors in this round

14 investors had bought by the notice of Dec 24, 2015: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ontario, Canada

People named in the notice

  • Cameron Piron · Executive Officer, Director
  • David Gallop · Executive Officer, Director
  • Gal Sela · Executive Officer, Director
  • Wesley Hodges · Executive Officer, Director
  • Andrew Prozes · Director
  • Doug Janzen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Cameron Piron, President. Source: SEC Form D, newest notice filed Dec 24, 2015. Read the notice at the SEC.

equitySEC
Jun 2015$2 MNo. 1$2 to $10 million

Synaptive Medical Inc.: Raise no. 1, Jun 2015

Investors in this round

26 investors had bought by the notice of Jun 17, 2015: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ontario, Canada

People named in the notice

  • Cameron Piron · Executive Officer, Director
  • David Gallop · Executive Officer, Director
  • Gal Sela · Executive Officer, Director
  • Wesley Hodges · Executive Officer, Director
  • Doug Janzen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Cameron Piron, President. Source: SEC Form D, newest notice filed Jun 17, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Synaptive Medical Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2019).

    SEC Form D · Apr 2019

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2019

That is all the official record says: Synaptive Medical Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Synaptive Medical Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 26 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Synaptive Medical Inc.
NameRoleNamed in
Cameron PironExecutive officerApr 2019
David Bruce GallopExecutive officerApr 2019
Peter Lee WehrlyExecutive officerApr 2019
Sandra Glen ClarkeExecutive officerApr 2019
George Peter DansExecutive officerDec 2018
Vincent Patrick LucianiExecutive officerJul 2017
William Patrick RyanExecutive officerJul 2017
David GallopExecutive officerOct 2016
Gal SelaExecutive officerOct 2016
James L. CloarExecutive officerOct 2016
Peter DansExecutive officerOct 2016
Wesley HodgesExecutive officerOct 2016
Andrew Glen ProzesDirectorApr 2019
Cameron PironDirectorApr 2019
David Bruce GallopDirectorApr 2019
David Glen CaluoriDirectorApr 2019
Douglas Glen JanzenDirectorApr 2019
Glenn Daniel Steele Jr.DirectorApr 2019
Peter Lee WehrlyDirectorApr 2019
Wesley HodgesDirectorApr 2019
David Peter CaluoriDirectorDec 2018
David Patrick CaluoriDirectorJul 2017
Michael DeManeDirectorJul 2017
Richard Lee ButlandDirectorJul 2017
Andrew ProzesDirectorOct 2016
David GallopDirectorOct 2016
Doug JanzenDirectorOct 2016
Gal SelaDirectorOct 2016